ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: Implications for the regulation of viral latency

Virology Journal

Volumn 3, Issue , 2006, Pages

  Halford, William P ^a   Weisend, Carla ^a   Grace, Jennifer ^a   Soboleski, Mark ^b   Carr, Daniel J J ^c   Balliet, John W ^d   Imai, Yumi ^e   Margolis, Todd P ^e   Gebhardt, Bryan M ^f  

^a MONTANA STATE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CYTOKINE RECEPTOR ANTAGONIST; GREEN FLUORESCENT PROTEIN; INTERFERON; PROTEIN ICP0; STAT1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEATH; FEMALE; GENE CONTROL; GENETIC ORGANIZATION; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCID MOUSE; TRIGEMINUS GANGLION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; CERCOPITHECUS AETHIOPS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; IMMEDIATE-EARLY PROTEINS; L CELLS (CELL LINE); MICE; MICE, INBRED BALB C; MICE, SCID; SIMPLEXVIRUS; STAT1 TRANSCRIPTION FACTOR; TRIGEMINAL GANGLION; UBIQUITIN-PROTEIN LIGASES; VERO CELLS; VIRAL PROTEINS; VIRUS LATENCY;

ANIMALIA; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 33748356480     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-44     Document Type: Article

References (68)

1. Honess RW, Roizman B: Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 1974, 14:8-19.
2. Fraser NW, Block T, Spivack JG: The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology 1992, 191:1-8.
3. Lee LY, Schaffer PA: A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts. J Virol 1998, 72:4250-4264.
4. Farrell MJ, Margolis TP, Gomes WA, Feldman LT: Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo. J Virol 1994, 68:5337-5343.
5. Everett RD, Orr A, Preston CM: A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO Journal 1998, 17:7161-7169.
6. Preston CM: Repression of viral transcription during herpes simplex virus latency. J Gen Virol 2000, 81:1-19.
7. Mulvey M, Poppers J, Sternberg D, Mohr I: Regulation of eIF2alpha phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J Virol 2003, 77:10917-10928.
8. Mohr I: Phosphorylation and dephosphorylation events that regulate viral mRNA translation. Virus Res 2006, 119:89-99.
9. Eidson KM, Hobbs WE, Manning BJ, Carlson P, DeLuca NA: Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol 2002, 76:2180-2191.
10. Lin R, Noyce RS, Collins SE, Everett RD, Mossman KL: The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 2004, 78:1675-1684.
11. Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW: Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A 2000, 97:6097-6101.
12. Aaronson DS, Horvath CM: A road map for those who know JAK-STAT. Science 2002, 296:1653-1655.
13. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW: Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002, 285:1-24.
14. Harle P, Sainz BJ, Carr DJ, Halford WP: The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology 2002, 293:295-304.
15. Mossman KL, Saffran HA, Smiley JR: Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol 2000, 74:2052-2056.
16. Mossman KL, Smiley JR: Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol 2002, 76:1995-1998.
17. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW: Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med 1999, 189:663-672.
18. Cerveny M, Hessefort S, Yang K, Cheng G, Gross M, He B: Amino acid substitutions in the effector domain of the gamma 34.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-alpha. Virology 2003, 307:290-300.
19. Luker GD, Prior JL, Song J, Pica CM, Leib DA: Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol 2003, 77:11082-11093.
20. Vollstedt S, Arnold S, Schwerdel C, Franchini M, Alber G, Di Santo JP, Ackermann M, Suter M: Interplay between Alpha/Beta and Gamma Interferons with B, T, and Natural Killer Cells in the Defense against Herpes Simplex Virus Type 1. J Virol 2004, 78:3846-3850.
21. Chee AV, Lopez P, Pandolfi PP, Roizman B: Promyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 Effects. J Virol 2003, 77(12):7101-7105.
22. Ellison AR, Yang L, Voytek C, Margolis TP: Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology 2000, 268:17-28.
23. Halford WP, Schaffer PA: Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants to establish wild-type levels of latency in vivo. J Virol 2000, 74:5957-5967.
24. Halford WP, Schaffer PA: ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J Virol 2001, 75:3240-3249.
25. Longerich T, Eisenbach C, Penzel R, Kremer T, Flechtenmacher C, Helmke B, Encke J, Kraus T, Schirmacher P: Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy. Liver Transpl 2005, 11:1289-1294.
26. Halford WP, Halford KJ, Pierce AT: Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replication. J Theor Biol 2005, 235:439-454.
27. Pierce AT, DeSalvo J, Foster TP, Kosinski A, Weller SK, Halford WP: Interferon-beta and interferon-gamma synergize to block viral DNA and virion synthesis in herpes simplex virusinfected cells. J Gen Virol 2005, 86:2421-2432.
28. Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Gesser RM, Wysocka M, Dillner A, Fraser NW: Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. J Virol 1992, 66:7336-7345.
29. Valyi-Nagy T, Gesser RM, Raengsakulrach B, Deshmane SL, Randazzo BP, Dillner AJ, Fraser NW: A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement. Virology 1994, 199:484-490.
30. Everett RD: ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 2000, 22:761-770.
31. Halford WP, Kemp CD, Isler JA, Davido DJ, Schaffer PA: ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J Virol 2001, 75:6143-6153.
32. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT: RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons. Science 1987, 235:1056-1059.
33. Farrell MJ, Dobson AT, Feldman LT: Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A 1991, 88:790-794.
34. Brown SM, Harland J, MacLean AR, Podlech J, Clements JB: Cell type and cell state determine differential in vitro growth of nonneurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J Gen Virol 1994, 75:2367-2377.
35. Bolovan CA, Sawtell NM, Thompson RL: ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol 1994, 68:48-55.
36. Mohr I, Gluzman Y: A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J 1996, 15:4759-4766.
37. Valyi-Nagy T, Fareed MU, O'Keefe JS, Gesser RM, MacLean AR, Brown SM, Spivack JG, Fraser NW: The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. J Gen Virol 1994, 75:2059-2063.
38. Speck P, Simmons A: Precipitous clearance of herpes simplex virus antigens from the peripheral nervous systems of experimentally infected C57BL/10 mice. J Gen Virol 1998, 79:561-564.
39. Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL: CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 2000, 191:1459-1466.
40. Khanna KM, Lepisto AJ, Hendricks RL: Immunity to latent viral infection: many skirmishes but few fatalities. Trends Immunol 2004, 25:230-234.
41. Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina SM, Hofman FM, Ghiasi H, Nesburn AB, Wechsler SL: Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000, 287:1500-1503.
42. Thompson RL, Sawtell NM: Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol 2001, 75:6660-6675.
43. Branco FJ, Fraser NW: Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis. J Virol 2005, 79:9019-9025.
44. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, Margolis TP: Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A 2002, 99:978-983.
45. Sawtell NM: Detection and quantification of the rare latently infected cell undergoing herpes simplex virus transcriptional activation in the nervous system in vivo. Methods Mol Biol 2005, 292:57-72.
46. Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR: Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis 2003, 187:542-549.
47. Morrison LA: Vaccines against genital herpes: progress and limitations. Drugs 2002, 62:1119-1129.
48. Buddingh GJ, Schrum DI, Lanier JC, Guidry DJ: Studies of the natural history of herpes simplex virus infections. Pediatrics 1953, 11:593-605.
49. Kinghorn GR: Epidemiology of genital herpes. J Int Med Res 1994, 22:14A-23A..
50. Decman V, Freeman ML, Kinchington PR, Hendricks RL: Immune control of HSV-1 latency. Viral Immunol 2005, 18:466-473.
51. Khanna KM, Lepisto AJ, Decman V, Hendricks RL: Immune control of herpes simplex virus during latency. Curr Opin Immunol 2004, 16:463-469.
52. Samaniego LA, Neiderhiser L, DeLuca NA: Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 1998, 72:3307-3320.
53. Cai W, Schaffer PA: Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol 1989, 63:4579-4589.
54. Cai W, Astor TL, Liptak LM, Cho C, Coen DM, Schaffer PA: The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol 1993, 67:7501-7512.
55. DeLuca NA, McCarthy AM, Schaffer PA: Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985, 56:558-570.
56. Halford WP, Balliet JD, Gebhardt BM: Re-evaluating natural resistance to herpes simplex virus type 1. J Virol 2004, 78:10086-10095.
57. Soboleski MR, Oaks J, Halford WP: Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J 2005, 19:440-442.
58. Sacks WR, Schaffer PA: Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol 1987, 61:829-839.
59. Treco DA: Preparation and analysis of DNA, p.2.0.3-2.2.3. In Current protocols in molecular biology Edited by: Ausubel FM. New York, N.Y. , John Wiley & Sons; 1990.
60. Siebert PD, Larrick JW: PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 1993, 14:244-249.
61. Hill JM, Halford WP, Wen R, Engel LS, Green LC, Gebhardt BM: Quantitative analysis of polymerase chain reaction products by dot blot. Anal Biochem 1996, 235:44-48.
62. Miller RD, Hogg J, Ozaki JH, Gell D, Jackson SP, Riblet R: Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proc Natl Acad Sci U S A 1995, 92:10792-10795.
63. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP: Role of PML in cell growth and the retinoic acid pathway. Science 1998, 279:1547-1551.
64. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al.: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
65. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-gamma receptor. Science 1993, 259:1742-1745.
66. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M: Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
67. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM: Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 1995, 69:4792-4796.
68. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD: Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84:431-442.